Amanda Hays, Ph.D.

Scientific Officer
BioAgilytix
Olathe, Kansas

Amanda Hays, Ph.D., Scientific Officer, offers more than a decade of lab experience in multiple fields, including pharmacology, drug metabolism, immunoassays, immunogenicity, biomarkers, flow cytometry and qPCR. She has particular expertise leading programs through all stages in the drug development process. In her current role, she serves as a Scientific Officer and provides global scientific leadership and technical guidance at BioAgilytix. Dr. Hays is the Chair of the AAPS biomarkers and precision medicine community and the AAPS qPCR working group, among other volunteer leadership positions. She earned her Ph.D. in pharmacology from the University of Kansas Medical Center in Kansas City (KS, USA).

Disclosure information not submitted.

Presentation(s):

• Rapid Fire: Beyond Legacy Therapeutics - Navigating the Path Less Traveled (CE)

  Monday, October 17, 2022
  3:00 PM – 4:00 PM ET

• AAPS Biomarkers & Precision Medicine Community Membership Meeting

  Monday, October 17, 2022
  5:00 PM – 6:00 PM ET

• Keynote: Surrogate Matrices – A Creative Solution to Scarcity, or Simply Sound Science?

  Tuesday, October 18, 2022
  1:30 PM – 2:30 PM ET

• Symposium: A Look Into the Future of Bioanalytics (CE)

  Wednesday, October 19, 2022
  9:00 AM – 11:00 AM ET

• Keynote: Bioanalytics Future State: Precise, Personal and Predictive

  Wednesday, October 19, 2022
  1:30 PM – 2:30 PM ET